Crossmark

CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer

Crossref DOI link: https://doi.org/10.1038/s41585-024-00901-y

Published Online: 2024-07-01

Published Print: 2025-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Smith, Danielle J. https://orcid.org/0000-0002-6708-5470
Lunj, Sapna

Adamson, Antony D. https://orcid.org/0000-0002-5408-0013
Nagarajan, Sankari https://orcid.org/0000-0001-8748-6223
Smith, Tim A. D. https://orcid.org/0000-0002-3945-630X
Reeves, Kimberley J.

Hoskin, Peter J. https://orcid.org/0000-0001-8323-9567
Choudhury, Ananya
License Information

Text and Data Mining valid from 2024-07-01

Version of Record valid from 2024-07-01
More Information

Article History

Accepted: 29 April 2024

First Online: 1 July 2024

Competing interests

: The authors declare no competing interests.